A new beginning in molecular medicine...

That’s what Principio means. At Principio, our mission is to develop and manufacture incredibly novel molecular imaging agents and therapeutic radiopharmaceuticals for the treatment of cancer, thus offering physicians better tools to treat patients and personalize therapy. And we are just getting started.

Recent News

2/10/2010 — Principio, Inc. Announces Licensing Agreement for Novel Molecular Imaging and Therapeutic Radiopharmaceuticals for theTreatment of Cancer with Johns Hopkins School of Medicine